DK1003528T3 - Fremgangsmåde til forøgelse af biotilgængeligheden af fexofenadin og dets derivater - Google Patents

Fremgangsmåde til forøgelse af biotilgængeligheden af fexofenadin og dets derivater

Info

Publication number
DK1003528T3
DK1003528T3 DK98935892T DK98935892T DK1003528T3 DK 1003528 T3 DK1003528 T3 DK 1003528T3 DK 98935892 T DK98935892 T DK 98935892T DK 98935892 T DK98935892 T DK 98935892T DK 1003528 T3 DK1003528 T3 DK 1003528T3
Authority
DK
Denmark
Prior art keywords
fexofenadine
bioavailability
derivatives
increasing
Prior art date
Application number
DK98935892T
Other languages
English (en)
Inventor
Gail H Hurst
Dennis H Giesing
Kin-Kai Hwang
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of DK1003528T3 publication Critical patent/DK1003528T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/745Polymers of hydrocarbons
    • A61K31/75Polymers of hydrocarbons of ethene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK98935892T 1997-08-14 1998-07-21 Fremgangsmåde til forøgelse af biotilgængeligheden af fexofenadin og dets derivater DK1003528T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91156397A 1997-08-14 1997-08-14
PCT/US1998/015098 WO1999008690A1 (en) 1997-08-14 1998-07-21 Method of enhancing bioavailability of fexofenadine and its derivatives

Publications (1)

Publication Number Publication Date
DK1003528T3 true DK1003528T3 (da) 2003-02-03

Family

ID=25430473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98935892T DK1003528T3 (da) 1997-08-14 1998-07-21 Fremgangsmåde til forøgelse af biotilgængeligheden af fexofenadin og dets derivater

Country Status (30)

Country Link
EP (1) EP1003528B1 (da)
JP (1) JP4295913B2 (da)
KR (1) KR100522985B1 (da)
CN (1) CN1143680C (da)
AR (1) AR018505A1 (da)
AT (1) ATE224721T1 (da)
AU (1) AU725965C (da)
BR (1) BR9811937A (da)
CA (1) CA2301267C (da)
CZ (1) CZ293666B6 (da)
DE (1) DE69808303T2 (da)
DK (1) DK1003528T3 (da)
EE (1) EE04263B1 (da)
ES (1) ES2179523T3 (da)
HK (1) HK1025901A1 (da)
HU (1) HU226823B1 (da)
ID (1) ID24463A (da)
IL (1) IL134521A (da)
NO (1) NO325148B1 (da)
NZ (1) NZ502133A (da)
OA (1) OA11287A (da)
PL (1) PL191607B1 (da)
PT (1) PT1003528E (da)
RU (1) RU2197967C2 (da)
SK (1) SK283868B6 (da)
TR (1) TR200000419T2 (da)
TW (1) TWI240633B (da)
UA (1) UA64765C2 (da)
WO (1) WO1999008690A1 (da)
ZA (1) ZA987221B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69624559T2 (de) 1995-02-28 2003-07-10 Aventis Pharma Inc Arzneizubereitungen für piperidinalkanolderivate
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
WO2003101437A2 (en) * 2002-05-29 2003-12-11 Aventis Pharmaceuticals Holdings Inc. Method of treating asthma using fexofenadine
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
KR101106374B1 (ko) 2009-06-05 2012-01-19 민병욱 고체연료에 의한 가연성 가스 발생 장치
KR101117014B1 (ko) * 2009-09-09 2012-06-14 민병욱 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치
CN101843616B (zh) * 2010-06-04 2011-07-27 西安万隆制药有限责任公司 一种盐酸非索非那定与微晶纤维素组合物及其制备方法
RU2453315C2 (ru) * 2010-08-17 2012-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Фармацевтическая композиция для лечения аллергических заболеваний
JP2014513708A (ja) 2011-05-20 2014-06-05 アベンティス・ファーマスーティカルズ・インコーポレイテツド フェキソフェナジンを含む医薬組成物
RU2504018C1 (ru) * 2012-05-28 2014-01-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте
RU2553362C1 (ru) * 2014-01-09 2015-06-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567592A (en) * 1994-02-02 1996-10-22 Regents Of The University Of California Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
WO1996040792A1 (en) * 1995-06-07 1996-12-19 Novo Nordisk A/S Modification of polypeptides
JPH11507356A (ja) * 1995-06-07 1999-06-29 アブマックス,インコーポレイティド 経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用

Also Published As

Publication number Publication date
JP2001515041A (ja) 2001-09-18
UA64765C2 (uk) 2004-03-15
CZ2000522A3 (cs) 2000-09-13
ES2179523T3 (es) 2003-01-16
WO1999008690A1 (en) 1999-02-25
AU725965C (en) 2004-04-22
ID24463A (id) 2000-07-20
PT1003528E (pt) 2003-02-28
EE200000069A (et) 2000-10-16
AR018505A1 (es) 2001-11-28
TWI240633B (en) 2005-10-01
CA2301267C (en) 2004-07-13
ZA987221B (en) 1999-02-15
HUP0003189A3 (en) 2001-04-28
AU8505098A (en) 1999-03-08
IL134521A0 (en) 2001-04-30
ATE224721T1 (de) 2002-10-15
PL338579A1 (en) 2000-11-06
CN1143680C (zh) 2004-03-31
CN1267221A (zh) 2000-09-20
EE04263B1 (et) 2004-04-15
NZ502133A (en) 2002-03-28
HU226823B1 (hu) 2009-11-30
CA2301267A1 (en) 1999-02-25
KR20010022845A (ko) 2001-03-26
PL191607B1 (pl) 2006-06-30
DE69808303D1 (de) 2002-10-31
BR9811937A (pt) 2000-09-05
RU2197967C2 (ru) 2003-02-10
SK1842000A3 (en) 2000-08-14
NO20000706L (no) 2000-04-13
SK283868B6 (sk) 2004-03-02
DE69808303T2 (de) 2003-05-22
OA11287A (en) 2003-10-22
NO20000706D0 (no) 2000-02-11
EP1003528B1 (en) 2002-09-25
KR100522985B1 (ko) 2005-10-21
NO325148B1 (no) 2008-02-11
EP1003528A1 (en) 2000-05-31
IL134521A (en) 2005-07-25
HK1025901A1 (en) 2000-12-01
JP4295913B2 (ja) 2009-07-15
HUP0003189A2 (en) 2001-03-28
CZ293666B6 (cs) 2004-06-16
TR200000419T2 (tr) 2000-09-21
AU725965B2 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
DK0952829T3 (da) Farmaceutisk præparat af fenofibrat med høj biologisk tilgængelighed og fremgangsmåde til dets fremstilling
DE69827481D1 (de) Giessverfahren
DK1044969T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser
NO995077L (no) Fremgangsmåte ved anvendelse av cyklooksygenase-2 inhibitorer
IS5952A (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS5982A (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20011886D0 (no) Utforminger av fexofenadin
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
DK0831098T3 (da) Mellemprodukter og fremgangsmåde til fremstilling af olanzapin
DK1003528T3 (da) Fremgangsmåde til forøgelse af biotilgængeligheden af fexofenadin og dets derivater
DK0792267T3 (da) 2-[(2-alkoxy-6-trifluormethylpyrimidin-4-yl)-oxymethylen]-phenyleddikesyrederivater, fremgangsmåde og mellemprodukter til d
DK1053217T3 (da) Fremgangsmåde til fremstilling af n-propanol
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
IS4980A (is) Aðferðir og milliefni við framleiðslu á setnum krómanól afleiðum
DK0970077T3 (da) Forbedret fremgangsmåde til fremstilling af thiazolidindioner og nye thiazolidindioner
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0983249T3 (da) Fremgangsmåder og mellemprodukter til fremstilling af substituerede indazolderivater
IS2273B (is) Aðferð fyrir nýsmíðina á HIV próteasa lötum
DK1023279T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
DK1062358T3 (da) Ny fremgangsmåde til fremstilling af fexofenadin
DK1036319T3 (da) Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf
DK1023292T3 (da) Fremgangsmåde til syntese af chlorpurinintermediater
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser